Horizon Therapeutics (HZNP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | HZNP | AMGN | BMY | GILD | ILMN |
| Company | Horizon Therapeutics | Amgen Inc | Bristol-Myers Squibb Company | Gilead Sciences Inc | Illumina Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | NASDAQ | NASDAQ |
| Open | 116.34 | 270.63 | 49.00 | 66.58 | 123.09 |
| High | 116.38 | 274.47 | 49.00 | 67.19 | 124.74 |
| Low | 116.26 | 269.65 | 48.55 | 66.37 | 120.82 |
| Last | 116.30 | 274.04 | 48.80 | 66.89 | 122.14 |
| Change | +0.05 | +0.50 | -0.19 | -0.14 | -2.32 |
| % Change | +0.04% | +0.18% | -0.39% | -0.21% | -1.86% |
| Volume | 28,881,200 | 772,841 | 8,582,479 | 2,843,421 | 362,823 |
| 20-Day Average Volume | 3,994,490 | 2,084,875 | 10,696,474 | 6,202,145 | 1,470,027 |
| Previous Close | 116.25 | 273.54 | 48.99 | 67.03 | 124.46 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 115.61 | 271.60 | 50.36 | 69.07 | 126.45 |
| 20-Day Raw Stochastic | 95.09% | 47.62% | 16.55% | 13.36% | 24.57% |
| 20-Day Relative Strength | 80.29% | 49.12% | 40.69% | 32.63% | 42.68% |
| Weighted Alpha | +49.30 | +11.69 | -26.25 | -20.96 | -38.09 |
| Today's Opinion | 88% Buy | 40% Sell | 88% Sell | 100% Sell | 88% Sell |
| Previous Opinion | 88% Buy | 40% Sell | 88% Sell | 100% Sell | 88% Sell |
| Last Month's Opinion | 40% Buy | 24% Buy | 8% Sell | 88% Sell | 24% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.53% since 09/28/23 | +3.75% since 04/17/24 | +1.90% since 04/17/24 | +0.05% since 04/17/24 | +2.89% since 04/17/24 |
| Low | 115.66 on 09/29/23 | 260.68 on 04/19/24 | 47.62 on 04/18/24 | 65.90 on 04/18/24 | 115.73 on 04/18/24 |
| High | 116.38 on 10/05/23 | 274.48 on 04/23/24 | 49.56 on 04/22/24 | 67.68 on 04/23/24 | 125.70 on 04/23/24 |
| 1-Month | |||||
| %Chg | +0.68% since 09/05/23 | -0.80% since 03/22/24 | -6.12% since 03/22/24 | -7.77% since 03/22/24 | -11.32% since 03/22/24 |
| Low | 114.75 on 09/11/23 | 260.68 on 04/19/24 | 47.62 on 04/18/24 | 65.90 on 04/18/24 | 115.73 on 04/18/24 |
| High | 116.38 on 10/05/23 | 288.57 on 03/28/24 | 54.47 on 03/28/24 | 73.87 on 03/28/24 | 140.07 on 03/28/24 |
| 3-Month | |||||
| %Chg | +12.95% since 07/05/23 | -10.32% since 01/24/24 | -2.97% since 01/24/24 | -15.80% since 01/24/24 | -13.69% since 01/24/24 |
| Low | 98.80 on 08/03/23 | 260.68 on 04/19/24 | 47.58 on 02/06/24 | 65.90 on 04/18/24 | 115.73 on 04/18/24 |
| High | 116.38 on 10/05/23 | 329.72 on 02/05/24 | 55.03 on 03/13/24 | 81.06 on 01/25/24 | 148.19 on 01/31/24 |
| 6-Month | |||||
| %Chg | +7.70% since 04/05/23 | -0.78% since 10/24/23 | -13.13% since 10/24/23 | -14.31% since 10/24/23 | +4.83% since 10/24/23 |
| Low | 90.56 on 05/16/23 | 249.70 on 10/31/23 | 47.58 on 02/06/24 | 65.90 on 04/18/24 | 89.00 on 11/10/23 |
| High | 116.38 on 10/05/23 | 329.72 on 02/05/24 | 56.77 on 10/25/23 | 87.86 on 01/19/24 | 148.19 on 01/31/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 26,632,118 | 146,720,288 | 99,290,928 | 83,457,512 | 19,820,878 |
| Shares Outstanding, K | 228,995 | 536,376 | 2,026,759 | 1,245,077 | 159,255 |
| Annual Sales | 3,629,040,000 | 28,190,000,000 | 45,006,000,000 | 27,116,000,000 | 4,504,000,000 |
| Annual Net Income | 521,480,000 | 6,717,000,000 | 8,025,000,000 | 5,665,000,000 | -1,161,000,000 |
| Last Quarter Sales | 944,960,000 | 8,196,000,000 | 11,477,000,000 | 7,114,000,000 | 1,122,000,000 |
| Last Quarter Net Income | 127,070,000 | 767,000,000 | 1,762,000,000 | 1,429,000,000 | -176,000,000 |
| 60-Month Beta | 1.03 | 0.58 | 0.39 | 0.19 | 1.19 |
| Per-Share Information | |||||
| Most Recent Earnings | 1.20 on 08/08/23 | 4.71 on 02/06/24 | 1.70 on 02/02/24 | 1.72 on 02/06/24 | 0.14 on 02/08/24 |
| Latest Earnings Date | 11/01/23 | 05/02/24 | 04/25/24 | 04/25/24 | 05/02/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | 0.600 on 04/04/24 | 0.770 on 03/14/24 | N/A |
| Next Ex-Dividends Date | N/A | 05/16/24 | 04/04/24 | 03/14/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 25.89 | 14.58 | 6.55 | 9.96 | 138.22 |